Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to collect postmarket data in subjects who receive surgical treatment of a full-thickness rotator cuff tear (of at least 1.5 cm) with the BioWick™ SureLock™ implant. Both performance and safety data will be collected.
Study Title Efficacy of the BioWick SureLock Implant for the Reattachment of Soft Tissue to Bone in Subjects Undergoing Rotator Cuff Repairs
Sponsor Cayenne Medical, Inc., a Zimmer Biomet company
Study Design The study is a prospective, non-randomized, open-label, single-arm study that includes both preoperative assessments and follow-up assessments at 3 months, 6 months, and 12 months.
Clinical Phase Postmarket
Number of Sites Up to ten sites in the U.S.
Study Duration per Subject Subjects will be enrolled in the study for up to 12 months.
Primary Objective The primary objective of this study is to assess survivorship (lack of reoperation/device removal) with the use of the BioWick SureLock implant.
Secondary Objective
The secondary objectives of this study are:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BioWick SureLock Implant | Experimental | All subjects are part of a single arm. All subjects received the BioWick SureLock implant. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BioWick SureLock Implant | Device | The BioWick SureLock implant is a device for shoulder and extremity surgery, constructed of Ultra High Molecular Weight Polyethylene Suture. BioWick SureLock is uniquely designed to minimize these risks by avoiding manual tensioning with an inserter mechanism that ensures that the implant is consistently deployed below the cortex. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Not Requiring Removal or Reoperation of the Implant | The primary endpoint of this study is survivorship (lack of reoperation/device removal) at 12 months postoperative. Implant survivorship for each subject was determined by whether the subject underwent a revision or reoperation of the study device. Survivorship was assessed using a Kaplan-Meier analysis. Possible scores range from 0% (lowest survivorship) to 100% (highest survivorship). | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Not Requiring Removal or Reoperation of the Implant | Implant survivorship (lack of reoperation/device removal) at 3 months and 6 months postoperative. Implant survivorship for each subject was determined by whether the subject underwent a revision or reoperation of the study device. Survivorship was assessed using a Kaplan-Meier analysis. Possible scores range from 0% (lowest survivorship) to 100% (highest survivorship). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ryan Boylan | ryan.boylan@zimmerbiomet.com | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Orthopaedic Clinic Association | Phoenix | Arizona | 85016 | United States | ||
| Eisenhower Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Any screened subjects who met any of the exclusion criteria were excluded from participation in this study and were not considered enrolled subjects.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | BioWick SureLock Implant | This arm included all subjects who were implanted with the BioWick SureLock Implant. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | BioWick SureLock Implant | This arm will include all subjects who are implanted with the BioWick SureLock Implant. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants Not Requiring Removal or Reoperation of the Implant | The primary endpoint of this study is survivorship (lack of reoperation/device removal) at 12 months postoperative. Implant survivorship for each subject was determined by whether the subject underwent a revision or reoperation of the study device. Survivorship was assessed using a Kaplan-Meier analysis. Possible scores range from 0% (lowest survivorship) to 100% (highest survivorship). | In the statistical analysis of the primary effectiveness endpoint of the study, only subjects with evaluable endpoint were used in the statistical analysis, i.e., a complete case analysis. | Posted | Count of Participants | Participants | 12 months |
|
3 months, 6 months, and 1 year
Adverse event data were collected throughout the entire duration of the study from enrollment thru subject completion. Routine adverse event collection occurred at each visit (3 months, 6 months, and 1 year).
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | BioWick SureLock Implant | This arm will include all subjects who are implanted with the BioWick SureLock Implant. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Stepped on a nail with right foot. | Infections and infestations | Systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Tear and retraction of entire supraspinatus tendon | Musculoskeletal and connective tissue disorders | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Madison Murphy | Zimmer Biomet | 5745262059 | madison.murphy@zimmerbiomet.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jun 22, 2020 | Feb 18, 2022 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D000070636 | Rotator Cuff Injuries |
| ID | Term |
|---|---|
| D012421 | Rupture |
| D014947 | Wounds and Injuries |
| D000070599 | Shoulder Injuries |
| D013708 | Tendon Injuries |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 3 months, 6 months |
| American Shoulder and Elbow Surgeons (ASES) Patient Self-Evaluation Score | Pain and function as measured by the American Society of Shoulder and Elbow Surgeons (ASES) questionnaire. ASES consists of 3 subcomponent scores including pain, instability, and activities of daily living. The pain score can be 0 to 10 with 0 being no pain and 10 being the worst pain imaginable. The instability score can be 0 to 10 with 0 being no instability and 10 being the worst instability imaginable. The activities of daily living consists of 10 questions with ordinal responses of 0, 1, 2, and 3 with 3 involving no limitation and 0 is unable to do. The 3 subcomponents combine to make the overall ASES score which can range from 0 to 100 with 0 being the worst possible score and 100 being the best. | Preoperative, 3 months, 6 months, 1 year |
| Visual Analogue Scale (VAS) Pain Score | A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms. Possible scores range from 0 (no pain) to 10 (very much pain). | Preoperative, 3 months, 6 months, 1 year |
| The Veterans RAND 12 (VR-12) Item Health Survey Physical Score | A brief, generic, multi-use, self-administered health survey comprised of 12 items. The instruments are primarily used to measure health-related quality of life, to estimate disease burden, and to evaluate the disease-specific impact on general and selected populations. A higher VR-12 score indicates better health (0-100 scale). | Preoperative, 3 months, 6 months, 1 year |
| The Veterans RAND 12 (VR-12) Item Health Survey Mental Score | A brief, generic, multi-use, self-administered health survey comprised of 12 items. The instruments are primarily used to measure health-related quality of life, to estimate disease burden, and to evaluate the disease-specific impact on general and selected populations. A higher VR-12 score indicates better health (0-100 scale). | Preoperative, 3 months, 6 months, 1 year |
| Range of Motion (ROM) - Active Forward Elevation | Range of motion (ROM): The full movement potential of a joint, usually its range of flexion and extension. Normal range for active forward elevation is 150-180 degrees. | Preoperative, 3 months, 6 months, 1 year |
| Device Safety | Safety evaluations were based on the frequency and incidence of device-related adverse events. Device-related adverse events included all reported adverse events classified as "Definitely" or "Possibly" related to the device. Adverse event data were collected throughout the entire duration of the study from enrollment thru subject completion. Routine collection occurred at each visit (3 months, 6 months, and 1 year). Additional details of reports of adverse events can be found in the Adverse Events section of the posted results. | 1 year |
| Rancho Mirage |
| California |
| 92270 |
| United States |
| Orthopaedic Medical Group of Tampa Bay PA | Brandon | Florida | 33511 | United States |
| Foundation for Orthopaedic Research and Eduation | Temple Terrace | Florida | 33637 | United States |
| Norton Orthopaedics and Sports Medicine | Louisville | Kentucky | 40241 | United States |
| University of Utah | Salt Lake City | Utah | 84108 | United States |
| University of Virginia | Charlottesville | Virginia | 22903 | United States |
| Withdrawal by Subject |
|
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Duration of Symptoms/Time Since Injury | Mean | Full Range | months |
|
| Current tobacco use | Count of Participants | Participants |
|
| Current alcohol use | Count of Participants | Participants |
|
| Prior Shoulder Operations | Count of Participants | Participants |
|
|
|
| Secondary | Number of Participants Not Requiring Removal or Reoperation of the Implant | Implant survivorship (lack of reoperation/device removal) at 3 months and 6 months postoperative. Implant survivorship for each subject was determined by whether the subject underwent a revision or reoperation of the study device. Survivorship was assessed using a Kaplan-Meier analysis. Possible scores range from 0% (lowest survivorship) to 100% (highest survivorship). | In the statistical analysis of the primary effectiveness endpoint of the study, only subjects with evaluable endpoint were used in the statistical analysis, i.e., a complete case analysis. | Posted | Count of Participants | Participants | 3 months, 6 months |
|
|
|
| Secondary | American Shoulder and Elbow Surgeons (ASES) Patient Self-Evaluation Score | Pain and function as measured by the American Society of Shoulder and Elbow Surgeons (ASES) questionnaire. ASES consists of 3 subcomponent scores including pain, instability, and activities of daily living. The pain score can be 0 to 10 with 0 being no pain and 10 being the worst pain imaginable. The instability score can be 0 to 10 with 0 being no instability and 10 being the worst instability imaginable. The activities of daily living consists of 10 questions with ordinal responses of 0, 1, 2, and 3 with 3 involving no limitation and 0 is unable to do. The 3 subcomponents combine to make the overall ASES score which can range from 0 to 100 with 0 being the worst possible score and 100 being the best. | The number analyzed at each interval represents the number of subjects who completed the respective follow-up visit, which may be less than the overall number of participants because of missed visits. | Posted | Mean | Standard Deviation | units on a scale | Preoperative, 3 months, 6 months, 1 year |
|
|
|
| Secondary | Visual Analogue Scale (VAS) Pain Score | A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms. Possible scores range from 0 (no pain) to 10 (very much pain). | The number analyzed at each interval represents the number of subjects who completed the respective follow-up visit, which may be less than the overall number of participants because of missed visits. | Posted | Mean | Standard Deviation | score on a scale | Preoperative, 3 months, 6 months, 1 year |
|
|
|
| Secondary | The Veterans RAND 12 (VR-12) Item Health Survey Physical Score | A brief, generic, multi-use, self-administered health survey comprised of 12 items. The instruments are primarily used to measure health-related quality of life, to estimate disease burden, and to evaluate the disease-specific impact on general and selected populations. A higher VR-12 score indicates better health (0-100 scale). | The number analyzed at each interval represents the number of subjects who completed the respective follow-up visit, which may be less than the overall number of participants because of missed visits. | Posted | Mean | Standard Deviation | score on a scale | Preoperative, 3 months, 6 months, 1 year |
|
|
|
| Secondary | The Veterans RAND 12 (VR-12) Item Health Survey Mental Score | A brief, generic, multi-use, self-administered health survey comprised of 12 items. The instruments are primarily used to measure health-related quality of life, to estimate disease burden, and to evaluate the disease-specific impact on general and selected populations. A higher VR-12 score indicates better health (0-100 scale). | The number analyzed at each interval represents the number of subjects who completed the respective follow-up visit, which may be less than the overall number of participants because of missed visits. | Posted | Mean | Standard Deviation | score on a scale | Preoperative, 3 months, 6 months, 1 year |
|
|
|
| Secondary | Range of Motion (ROM) - Active Forward Elevation | Range of motion (ROM): The full movement potential of a joint, usually its range of flexion and extension. Normal range for active forward elevation is 150-180 degrees. | The number analyzed at each interval represents the number of subjects who completed the respective follow-up visit, which may be less than the overall number of participants because of missed visits. | Posted | Mean | Standard Deviation | degrees | Preoperative, 3 months, 6 months, 1 year |
|
|
|
| Secondary | Device Safety | Safety evaluations were based on the frequency and incidence of device-related adverse events. Device-related adverse events included all reported adverse events classified as "Definitely" or "Possibly" related to the device. Adverse event data were collected throughout the entire duration of the study from enrollment thru subject completion. Routine collection occurred at each visit (3 months, 6 months, and 1 year). Additional details of reports of adverse events can be found in the Adverse Events section of the posted results. | All enrolled subjects were analyzed for device safety through the end of their study participation. | Posted | Number | device-related adverse events | 1 year |
|
|
|
| 1 |
| 71 |
| 5 |
| 71 |
| 29 |
| 71 |
| Increased pain, loose rotator cuff anchor (non-study device) | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Bowel obstruction | Gastrointestinal disorders | Systematic Assessment |
|
| Chest pain and received heart catheter | Cardiac disorders | Systematic Assessment |
|
| Chest pain | Cardiac disorders | Systematic Assessment |
|
| Left knee OA | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Subject death after no longer able to breathe | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Adhesive capsulitis | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| 3 month MRI shows recurrent full-thickness tear of the supraspinatus | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Right rotator cuff tear | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Worsening of left shoulder pain | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Patient is stiff at 3 month and 6 month visit | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Tightness in trigger points within the cervical paraspinous muscles and levator scapular muscle | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Right (contralateral) shoulder pain after fall | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Neck pain - post op cervical discectomy | Nervous system disorders | Systematic Assessment |
|
| Full thickness defect of the anterior supraspinatus tendon just medial to the biowick anchors | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Left shoulder pain with certain movements | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Patient presented with ipsilateral bursitis/adhesive capsulitis | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Headaches for 2 weeks | General disorders | Systematic Assessment |
|
| Patient healed quickly and subsequently developed capsulitis | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Right shoulder pain | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Medial meniscus tear on right knee | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Patient fell off bike and ruptured his achilles tendon | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Metal shaving in left 3rd toe | General disorders | Systematic Assessment |
|
| Increased pain in right shoulder and neck radiating to fingers | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Presented to the ed with complaints of cough and wheezing x 2 weeks | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| At 3 month visit, patient is noted to be stiff | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Melanoma excision on right shoulder | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Patient developed lateral epicondylitis of right humerus | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| 6 month MRI report notes a re-tear of the supraspinatus and associated bursal-sided fluid build-up | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Sharp stabbing pain down middle of back. Preexisting back pain got much worse right after surgery | Nervous system disorders | Systematic Assessment |
|
| Adhesive capsulitis/arthro fibrosis diagnosed. | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Loosened posterior superior anchor with fluid collection and retraction. | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Worsening of lumbar degenerative disc disease | Nervous system disorders | Systematic Assessment |
|
| Capsulitis/stiffness. Required cortisone injection | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| 3/4 weeks post-op, patient developed erythema. Required surgical debridement and ROH. | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Patient presented to the pain clinic with known history of migraine headaches | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| New full-thickness tear at the supraspinatus/infraspinatus junction from shoveling. | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Low back pain with radiation into left thigh | Nervous system disorders | Systematic Assessment |
|
| Neck pain and decreased ROM related to degenerative cervical disc disease | Nervous system disorders | Systematic Assessment |
|
| COPD | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| 3 month MRI reports recurrent tear which becomes symptomatic sometimes | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| R shoulder pain/difficulty with throwing activities and shoulder movement | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
| Urinary retention | Renal and urinary disorders | Systematic Assessment |
|
| New tenderness of left shoulder | Musculoskeletal and connective tissue disorders | Systematic Assessment |
|
Not provided
Not provided
|
| 6 months |
|
|
| 12 months |
|
|
|
| 6 months |
|
|
| 1 year |
|
|
|
| 6 months |
|
|
| 1 year |
|
|
|
| 6 months |
|
|
| 1 year |
|
|
|
| 6 months |
|
|
| 1 year |
|
|